| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w16879 |
| 来源ID | Working Paper 16879 |
| A Primer on the Economics of Prescription Pharmaceutical Pricing in Health Insurance Markets | |
| Ernst R. Berndt; Thomas G. McGuire; Joseph P. Newhouse | |
| 发表日期 | 2011-03-14 |
| 出版年 | 2011 |
| 语种 | 英语 |
| 摘要 | The pricing of medical products and services in the U.S. is notoriously complex. In health care, supply prices (those received by the manufacturer) are distinct from demand prices (those paid by the patient) due to health insurance. The insurer, in designing the benefit, decides what prices patients pay out-of-pocket for drugs and other products. In this primer we characterize cost and supply conditions in markets for generic and branded drugs, and apply basic tools of microeconomics to describe how an insurer, acting on behalf of its enrollees, would set demand prices for drugs. Importantly, we show how the market structure on the supply side, characterized alternatively by monopoly (unique brands), Bertrand differentiated product markets (therapeutic competition), and competition (generics), influences the insurer's choices about demand prices. This perspective sheds light on the choice of coinsurance versus copayments, the structure of tiered formularies, and developments in the retail market. |
| 主题 | Microeconomics ; Market Structure and Distribution ; Health, Education, and Welfare ; Health ; Industrial Organization ; Market Structure and Firm Performance ; Industry Studies |
| URL | https://www.nber.org/papers/w16879 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/574556 |
| 推荐引用方式 GB/T 7714 | Ernst R. Berndt,Thomas G. McGuire,Joseph P. Newhouse. A Primer on the Economics of Prescription Pharmaceutical Pricing in Health Insurance Markets. 2011. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w16879.pdf（805KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
